Recent

% | $
Quotes you view appear here for quick access.

Geron Corporation Message Board

supine_detectum 12 posts  |  Last Activity: Jul 11, 2016 11:09 AM Member since: Mar 27, 2009
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • supine_detectum supine_detectum Jul 11, 2016 11:09 AM Flag

    One point worth mentioning is that when our founding fathers spoke about the right to bear arms, the "arms" they were talking about were Muskets. A typical musket firing at a single man-sized target was only accurate to about 40 to 50 yds using the ammunition of the day.

    To prepare to fire you had to
    Place gun in left hand to load position. Get the cartridge and tear cartridge with your two front teeth. Pour contents of cartridge into the barrel, including the bullet which you should push down with your finger. Draw rammer for use, then ram cartridge into the base of the barrel. Take ram rod out of the barrel and return to its proper location. Prime the cap to ignite the gunpowder inside then shoulder the Musket aim and fire.

    Needless to say there were No mass shootings by an individual using a Musket.

  • Reply to

    2032?

    by blackmarango Jul 1, 2016 9:44 AM
    supine_detectum supine_detectum Jul 1, 2016 11:57 AM Flag

    Your diagnosis is a cranio-rectal inversion. An extension of the patent of Imetelstat is absolutely, undeniably a good thing for Geron and investors. In terms of any future buyout of Geron by J&J or whoever 8 more protected years for Imetestat is a Very positive value proposition. I bet if a search was done on your posts we could find disparaging posts about the short time the original patent to 2024 and how Chippy was responsible for that.

    The fact that you can never see any good in anything Geron management acheives is remarkable and revealing. Sure, two sides of a viepoint are valuable but really, every day, all the time negative, sarcastic, condescending, unrelenting 22,000 + posts that many consider useless!! It seems you are so consumed with anger and hatred that one can only feel bad for you. Never-the-less my best to you and hopefully one day you can let this all consuming negativity/hatred go.

    Sentiment: Buy

  • Reply to

    Some speculating about the PDCO summary

    by sdrawkcabeman Jun 29, 2016 11:31 PM
    supine_detectum supine_detectum Jun 30, 2016 11:05 AM Flag

    I like IKE

    Sentiment: Strong Buy

  • Reply to

    Stop looking at pps daily

    by gernmeup Jun 28, 2016 11:49 AM
    supine_detectum supine_detectum Jun 28, 2016 7:05 PM Flag

    O kpail I'm hooked
    J&J doing a headstand.
    ʕ&ʕ

  • Reply to

    Stop looking at pps daily

    by gernmeup Jun 28, 2016 11:49 AM
    supine_detectum supine_detectum Jun 28, 2016 7:01 PM Flag

    paily K
    or
    J&J spelled backwards =
    YAJ & YAJ

  • Reply to

    Nice end

    by jwjmurphy Jun 28, 2016 4:02 PM
    supine_detectum supine_detectum Jun 28, 2016 4:10 PM Flag

    9% up and ending with the PPS at the day's high. If you expected better why?

  • Reply to

    Stop looking at pps daily

    by gernmeup Jun 28, 2016 11:49 AM
    supine_detectum supine_detectum Jun 28, 2016 3:11 PM Flag

    Don, Nah I totally disagree. Other companies with out any other drug in their pipeline obtaining an FDA approval for their first have seen their PPS significantly rise. The license with J&J is greatly positive in that the infrastructure is already in place to manufacture and distribute Imetelstat. Sales relations are already in Place, relations with MDs are already in Place, Pharmacy connections are already in Place, and the financial power to do all the above is solid and stable.

    If Geron had to do all the above, then yes maybe the market could question if Geron management had the talent to not only invent the drug and get it through a clinical trial but to Market and Distribute it and or the funds to get that done.

    J&J's world wide Infrastructure insures fast and efficient marketing and distribution of Imetelstat. Thus, any delay between IMET FDA approval and PPS is extremely unlikely.

    The fact that the 24/7 nay sayers here, like Black M are now trying to downplay FDA approval makes me suspect that the short contingent is trying to get in their last hurrah. Times they are a changing at Geron and those that cling to Geron's past performance will be swept aside.

    Sentiment: Buy

  • Reply to

    Stop looking at pps daily

    by gernmeup Jun 28, 2016 11:49 AM
    supine_detectum supine_detectum Jun 28, 2016 12:32 PM Flag

    Donny what would make you think that with a J&J backed and licensed drug, Geron would not go up after FDA approval? That just doesn't make any sense even considering your global pessimistic posts here.

  • Reply to

    Patient or Investor?

    by blackmarango Jun 26, 2016 8:38 AM
    supine_detectum supine_detectum Jun 26, 2016 12:21 PM Flag

    The cold hard reason for a low PPS is there are "No" drugs on the market at this time. If you don't have the patience or the fortitude to wait for the results of the Phase II/III clinical trials then leave, put your money somewhere else.

  • supine_detectum supine_detectum Jun 23, 2016 10:54 PM Flag

    LOL my mistake. Just look at it with crossed eyes.

  • Reply to

    Imbark's schedule

    by sdrawkcabeman Jun 23, 2016 12:56 PM
    supine_detectum supine_detectum Jun 23, 2016 6:56 PM Flag

    Mruyog, I seem to recall that the complete manufacturing of IMET and distribution is already taken over by Janssen and that Geron is only advising on the clinical trial process.

    Sentiment: Buy

  • supine_detectum supine_detectum Jun 12, 2016 10:29 PM Flag

    Thank you for this information.

    Sentiment: Buy

GERN
2.67+0.02(+0.75%)Aug 25 4:00 PMEDT